中国麻风皮肤病杂志 ›› 2024, Vol. 40 ›› Issue (12): 866-869.doi: 10.12144/zgmfskin202412866

• 临床研究 • 上一篇    下一篇

维持血液透析并发获得性反应性穿通性胶原病二例并文献复习

郑林,莫友,李倩,思远,佘浠宁,白靖竹,唐奕,李群,方锐华   

  1. 广州市第一人民医院皮肤科,广东广州,510180
  • 出版日期:2024-12-15 发布日期:2024-10-31

Acquired reactive penetrating collagenosis in patients treated with maintenance hemodialysis: two cases report and literature review

ZHENG Lin, MO You, LI Qian, SI Yuan, SHE Xining, BAI Jingzhu, TANG Yi, LI Qun, FANG Ruihua   

  1. Department of Dermatology, Guangzhou First People's Hospital, Guangzhou 510180, China
  • Online:2024-12-15 Published:2024-10-31

摘要: 获得性反应性穿通性胶原病(ARPC)通常与多种系统性疾病相关。本文报道2例血液透析的患者发生ARPC。患者1,自血液透析后开始出现面部丘疹,渐蔓延至全身,瘙痒明显;患者2,透析13年后出现全身丘疹和瘙痒症状,两例患者均经实验室检查和皮肤组织病理学检查确诊为ARPC。治疗上患者1起初给予抗组胺治疗,效果不佳,后改为度普利尤单抗治疗,皮疹消退;患者2给予口服氯雷他定、外用糖皮质激素软膏治疗,皮疹消退。

关键词: 血液透析, 获得性反应性穿通性胶原病, 度普利尤单抗

Abstract: Acquired reactive perforating collagenosis (ARPC) is usually associated with a variety of systemic diseases. We report two cases with ARPC undergoing hemodialysis. For patient 1, facial papules began to appear after hemodialysis and gradually spread throughout the body, with obvious pruritus; for patient 2, systemic papules and pruritus occurred 13 years after dialysis. Both patients were diagnosed with ARPC through laboratory tests and skin histopathological examinations. In terms of treatment, patient 1 was initially given antihistamine treatment, but the effect was not good. Later, dupilumab treatment was changed, and the rash subsided; patient 2 was given oral loratadine and topical glucocorticoid ointment treatment, and the rash subsided.

Key words: hemodialysis, acquired reactive penetrating collagenosis, dupilumab